Stockreport

Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics [Yahoo! Finance]

Tempus AI, Inc. - Class A  (TEM) 
PDF medicine and patient care, today reported financial results for the quarter that ended September 30, 2024. The company also announced that it has entered into an agreeme [Read more]